The size of the Europe Advanced Infusion Systems Market is estimated to be growing at a prominent rate between 2020 to 2025.
Infusion systems are medical instruments and disposables, which are used to distribute fluids or administer drugs in the form of solution to the patient’s circulatory system in a precise, controlled and systematic manner. There are various methods to administer a drug into the patient’s system, of which, the most used mode is through intravenous, although arterial, subcutaneous and epidural infusion are more favorable.
Advanced Infusion Systems’ popularity is mainly because of their dependable, ergonomic design and easy-to-use features. These pumps have bolstered their position in a wide range of application areas including diabetes, oncology, enteral feeding pain management, and general infusion. Features like visual monitoring, easy start up, mobility of system, steady and continuous infusion of multiple drugs at the same time, patient safety some of the major factors that are furthering the growth of the potential market of advanced infusion systems over conventional ones.
Increasing use of infusion products in homecare with encouraging reimbursements has hugely boosted this market. Immensely developed technology in infusion systems which eliminates user-related risks, safety, therapeutic effectiveness, higher bioavailability, increase in healthcare spending are also some other factors that propel the growth of the market. However, to operate these advanced infusion systems, extensive training is required. The presence of strict regulations for product approval and possible medication errors associated with infusion pump may restrain the growth of the market during the forecast period.
Europe Advanced Infusion Systems Market is segmented based on type of application, type of product and end-users. Applications are segmented into Clinical Nutrition, Chemotherapy, Pain Management, Diabetes and Asthma Treatment. Product type is segmented into Disposable Infusion System, Elastomeric Infusion System, Ambulatory Infusion System, Volumetric Infusion System, Patient Controlled Analgesia Pump, Syringe Infusion System and Implantable Infusion System. End-users has been further segmented as Diagnostic Centers, Hospitals and Ambulatory Surgical Centers. Further, on the basis of geography, the Europe market is analyzed under various regions namely UK, Spain, Italy, Germany and France. North America commands the largest regional segment of the global advanced infusion systems market. In 2019, North America accounted for the largest share, with 48.7% of the market, followed by Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
Hospira, Inc., is a market leader in infusion technologies globally. The major players in these markets are AngioDynamics, Inc., Medtronic, Inc., Terumo Corporation, Johnson & Johnson, CareFusion Corporation, Animas Corporation, Baxter International, Inc., B. Braun Melsungen AG, I-Flow Corporation, and F. Hoffmann-La Roche Ltd.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Application
5.1.1 Introduction
5.1.2 Clinical Nutrition
5.1.3 Chemotherapy
5.1.4 Pain Management
5.1.5 Diabetes
5.1.6 Asthma
5.1.7 Y-o-Y Growth Analysis, By Application
5.1.8 Market Attractiveness Analysis, By Application
5.1.9 Market Share Analysis, By Application
5.2 Product
5.2.1 Introduction
5.2.2 Disposable Infusion System
5.2.3 Elastomeric Infusion System
5.2.4 Ambulatory Infusion System
5.2.5 Volumetric Infusion System
5.2.6 Patient Controlled Analgesia Pump
5.2.7 Syringe Infusion System
5.2.8 Implantable Infusion System
5.2.9 Y-o-Y Growth Analysis, By Product
5.2.10 Market Attractiveness Analysis, By Product
5.2.11 Market Share Analysis, By Product
5.3 End-User
5.3.1 Introduction
5.3.2 Diagnostic Centers
5.3.3 Hospitals
5.3.4 Ambulatory Surgical Centers
5.3.5 Y-o-Y Growth Analysis, By End-User
5.3.6 Market Attractiveness Analysis, By End-User
5.3.7 Market Share Analysis, By End-User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Application
6.1.3.3 By Product
6.1.3.4 By End-User
6.1.4 Market Attractiveness Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Application
6.1.3.3 By Product
6.1.3.4 By End-User
6.1.5 Market Share Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Application
6.1.3.3 By Product
6.1.3.4 By End-User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Hospira, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 AngioDynamics, Inc.
8.3 Medtronic, Inc.
8.4 Terumo Corporation
8.5 Johnson & Johnson
8.6 CareFusion Corporation
8.7 Animas Corporation
8.8 Baxter International Inc.
8.9 B. Braun Melsungen AG
8.10 I-Flow Corporation
8.11 F. Hoffmann-La Roche Ltd
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
